![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Åsberg Anders Rollag Halvor Hartmann Anders
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.11, Iss.7, 2010-05, pp. : 1159-1166
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics, Vol. 48, Iss. 6, 2009-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Valganciclovir proves its value in CMV prevention
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 608, 2010-01 ,pp. :